A research programme by the Access to Medicine Foundation
  • Best practices
  • Innovative practice: Systematic approach to identify access challe...
Innovative practice

Systematic approach to identify access challenges

Company:

Roche Holding AG

What:

A comprehensive Access Planning Framework to determine current access levels in countries, and how its initiatives contribute to access.

Region:

Global

Aim:

To provide locally tailored access plans in four key areas: awareness, diagnosis, healthcare capacity and
funding.

Context:

Access to healthcare is a multidimensional challenge, with local
access often closely linked with the way a local healthcare system works.

In 2015, Roche created and began to roll out its Access Planning Framework. Access to healthcare is a multidimensional challenge, with local access often closely linked with the way a local healthcare system works. Through its framework, Roche is focusing on providing locally tailored access plans in four key areas: awareness, diagnosis, healthcare capacity and funding.

How does the framework support Roche's access efforts?
To address these areas and find solutions, Roche is working to build an understanding of the reasons why people in particular countries and regions lack access to opportunity for diagnosis and medicines. Using a systematic approach, it analyses each of the countries in scope where it operates, aiming to identify relevant stakeholders such as local communities or healthcare professionals, and capture specific issues of access, such as gaps in infrastructure, cultural barriers and financial constraints.

Roche then creates a detailed, comprehensive access plan for each country. Plans become part of its Access Planning Framework, and are embedded in the company’s overall business strategy. By the end of 2017, it had plans in place for more than 70 countries in scope. To support the continuance of its Framework, Roche consequently developed a comprehensive Patient Access Dashboard aimed at assessing, at a country level, current access levels, and how its strategies and initiatives contribute to improve access.

In addressing obstacles to diagnosis and treatment, Roche seeks to benefit those in low- and middle-income countries with health problems, improving their journeys to gain care. By working systematically to identify the particular challenges that exist at national and regional levels around how patients interact with healthcare systems, Roche represents innovation in this area.


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.